<DOC>
	<DOCNO>NCT01093742</DOCNO>
	<brief_summary>- Study Design - Randomized , Double-blind , Placebo-controlled , escalate single-dose design . - Four ascend dose cohort . - In cohort , subject randomize receive single dose HM10560A placebo ( negative control ) . - Objectives - The primary objective study assess safety tolerability single escalate subcutaneous dos HM10560A healthy male subject .</brief_summary>
	<brief_title>A Study HM10560A Healthy Male Subject</brief_title>
	<detailed_description>The secondary objective study follow : - To assess pharmacokinetics ( PK ) pharmacodynamics ( PD ) single subcutaneous dose HM10560A .</detailed_description>
	<criteria>1 . Healthy male volunteer , age range 20 54 year inform investigational nature study voluntarily agree participate study 2 . Body mass index ≥19 ≤26 Subject 3 . Medically healthy clinically significant screen result Physical examination , 12 lead ECG , Laboratory test 4 . Able participate procedure 5 . SBP 90140 mmHg , DBP 6090 mmHg , Pulse rate 5090 times/min 6 . AST , ALT &lt; 1.5 X UNL , CPK &lt; 2 X UNL 7 . Able abstain alcohol smoke study period 8 . Consented contraception 2 month end study 1 . Acute infection history within 14 day 2 . Prior exposure hypersensitivity recombinant human growth hormone 3 . Positive finding HBsAg , AntiHAV IgM , antiHCV , HIV Ag , HIV Ab syphilis high quality regain test 4 . History significant gastrointestinal , cardiac , pulmonary , hepato nephro disease 5. psychiatric disorder , malignancy tumor , hormonal disorder , diabetes mellitus hypertension history immunosuppressant treatment 6 . Caffeine , alcohol smoke abuse 7 . History hemophilia anticoagulant treatment 8 . Revulsion and/or panic syringe needle hypersensitivity subcutaneously administration 9 . History drug abuse positive test amphetamine , barbiturate , cocaine , opiates , benzodiazepines 10 . Blood donation significant blood loss within 60 day prior Day 1 . Plasma donation transfusion within 30 day prior Day 1 . 11 . Receipt another investigational medication within 60 day prior Day 1 12 . Use herbal product within 30 day prescription medication within 14 day overthecounter medication within 7 day prior Day 1 . 13 . Subjects unlikely comply protocol requirement , instruction study relate restriction</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>54 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Healthy</keyword>
</DOC>